AbCellera Biologics (ABCL) Shares Issued (2021 - 2022)

AbCellera Biologics (ABCL) posted Shares Issued of $22.5 million for Q3 2022, up 8.45% on a QoQ basis from $20.7 million in Q2 2022, and up 25.01% year-over-year from $18.0 million in Q3 2021.

AbCellera Biologics (ABCL) Shares Issued (2021 - 2022) Analysis & Trends

AbCellera Biologics' Shares Issued history runs 2 years deep, the most recent figure standing at $22.5 million for Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 19.44 Mn
10 AbCellera Biologics 1.72 Bn 1.72 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 22.46 Mn
Sep 30, 2022 22.46 Mn
Jun 30, 2022 20.71 Mn
Jun 30, 2022 20.71 Mn
Mar 31, 2022 37.53 Mn
Mar 31, 2022 37.53 Mn
Sep 30, 2021 17.96 Mn
Sep 30, 2021 17.96 Mn
Jun 30, 2021 45.68 Mn
Jun 30, 2021 45.68 Mn
Mar 31, 2021 1.58 Mn
Mar 31, 2021 1.58 Mn